Bjorn H. Ebdrup

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 168 publications

Neurometabolites and Antipsychotic Response in Psychosis: A Mega-Analysis.

Neurometabolites and Antipsychotic Response in Psychosis: A Mega-Analysis.

Journal: JAMA psychiatry

Published: June 24, 2026

Early Life Neurodevelopmental Indicators of Attention-Deficit/Hyperactivity Disorder at Age 10: A Prospective Cohort Study.

Early Life Neurodevelopmental Indicators of Attention-Deficit/Hyperactivity Disorder at Age 10: A Prospective Cohort Study.

Journal: Acta paediatrica (Oslo, Norway : 1992)

Published: May 28, 2026

High-Dose Vitamin D3 Supplementation During Pregnancy and Test-Based Cognitive Performance at Age 10 Years: A Post Hoc Secondary Analysis of a Randomized Clinical Trial.

High-Dose Vitamin D3 Supplementation During Pregnancy and Test-Based Cognitive Performance at Age 10 Years: A Post Hoc Secondary Analysis of a Randomized Clinical Trial.

Journal: JAMA network open

Published: May 18, 2026

Incidence of systemic physical multimorbidity among people with schizophrenia-spectrum or bipolar-spectrum disorders compared with age-matched and sex-matched individuals in Queensland, Australia: a statewide, hospital cohort study.

Incidence of systemic physical multimorbidity among people with schizophrenia-spectrum or bipolar-spectrum disorders compared with age-matched and sex-matched individuals in Queensland, Australia: a statewide, hospital cohort study.

Journal: The lancet. Psychiatry

Published: March 15, 2026

Comparative profiles of anomalous self-experiences and social cognition in clinical high risk for psychosis and autism spectrum disorder.

Comparative profiles of anomalous self-experiences and social cognition in clinical high risk for psychosis and autism spectrum disorder.

Journal: Schizophrenia research. Cognition

Published: March 11, 2026

Confirmatory factor analysis of competing PANSS negative symptom models: data from OPTiMiSE first-episode schizophrenia study.

Confirmatory factor analysis of competing PANSS negative symptom models: data from OPTiMiSE first-episode schizophrenia study.

Journal: BJPsych open

Published: December 12, 2025

Subtle impairments of facial emotion expressions in individuals at ultra-high risk for psychosis.

Subtle impairments of facial emotion expressions in individuals at ultra-high risk for psychosis.

Journal: Frontiers in psychiatry

Published: November 10, 2025

Inflammation in pregnancy and child neurodevelopment: A trio polygenic score and Mendelian randomization study in the Norwegian Mother, Father and Child Cohort Study.

Inflammation in pregnancy and child neurodevelopment: A trio polygenic score and Mendelian randomization study in the Norwegian Mother, Father and Child Cohort Study.

Journal: Brain, behavior, and immunity

Published: October 23, 2025

Persistent negative symptoms in the EULAST cohort: impact on functional outcome.

Persistent negative symptoms in the EULAST cohort: impact on functional outcome.

Journal: Schizophrenia (Heidelberg, Germany)

Published: October 18, 2025

Relapse in Schizophrenia: A Systematic Review of Criteria for Clinical Studies and International Consensus Guidelines to Improve Them.

Relapse in Schizophrenia: A Systematic Review of Criteria for Clinical Studies and International Consensus Guidelines to Improve Them.

Journal: The American journal of psychiatry

Published: October 08, 2025

Study protocol for a randomized clinical pilot trial investigating feasibility and efficacy of augmenting a virtual reality-assisted intervention targeting auditory verbal hallucinations with biofeedback: The Neuro-VR study.

Study protocol for a randomized clinical pilot trial investigating feasibility and efficacy of augmenting a virtual reality-assisted intervention targeting auditory verbal hallucinations with biofeedback: The Neuro-VR study.

Journal: PloS one

Published: September 17, 2025

Alleviating negative symptoms in schizophrenia using a virtual reality-based therapy targeting social reward learning (ENGAGE): Protocol for a randomised, controlled, assessor-blind pilot study.

Alleviating negative symptoms in schizophrenia using a virtual reality-based therapy targeting social reward learning (ENGAGE): Protocol for a randomised, controlled, assessor-blind pilot study.

Journal: PloS one

Published: August 28, 2025

Showing 1-12 of 168

Last Updated: 09/26/2026